187 related articles for article (PubMed ID: 35755142)
1. Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas.
Boyce TG; Christianson B; Hanson KE; Dunn D; Polter E; VanWormer JJ; Williams CL; Belongia EA; McLean HQ
Vaccine X; 2022 Aug; 11():100180. PubMed ID: 35755142
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
[TBL] [Abstract][Full Text] [Related]
3. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina.
Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS
Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834
[TBL] [Abstract][Full Text] [Related]
4. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
5. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial.
Miao Y; Mzolo T; Pellegrini M
Infect Dis Ther; 2019 Sep; 8(3):335-341. PubMed ID: 31377946
[TBL] [Abstract][Full Text] [Related]
7. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
[TBL] [Abstract][Full Text] [Related]
8. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Fredua B; Singleton JA; Stokley S
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):718-723. PubMed ID: 31437143
[TBL] [Abstract][Full Text] [Related]
9. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496
[TBL] [Abstract][Full Text] [Related]
10. Strategies for increasing adolescent immunizations in diverse ethnic communities.
Greenfield LS; Page LC; Kay M; Li-Vollmer M; Breuner CC; Duchin JS
J Adolesc Health; 2015 May; 56(5 Suppl):S47-53. PubMed ID: 25863555
[TBL] [Abstract][Full Text] [Related]
11. The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines.
Caldwell AC; Madden CA; Thompson DM; Garbe MC; Roberts JR; Jacobson RM; Darden PM
Hum Vaccin Immunother; 2021 Apr; 17(4):1059-1067. PubMed ID: 33074774
[TBL] [Abstract][Full Text] [Related]
12. A Multivariate Probit Regression of the Uptake of Adolescent Vaccines Among Racial/Ethnic Minority Adolescents Before and During the COVID-19 Pandemic.
Ejezie CL; Shegog R; Durand C; Cuccaro P; Savas LS
J Adolesc Health; 2024 Jan; 74(1):28-35. PubMed ID: 37804299
[TBL] [Abstract][Full Text] [Related]
13. Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics.
Pruitt SL; Tiro JA; Kepka D; Henry K
Am J Prev Med; 2022 Apr; 62(4):538-547. PubMed ID: 35125272
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers.
Goessl CL; Christianson B; Hanson KE; Polter EJ; Olson SC; Boyce TG; Dunn D; Williams CL; Belongia EA; McLean HQ; VanWormer JJ
BMC Public Health; 2022 Jul; 22(1):1322. PubMed ID: 35810274
[TBL] [Abstract][Full Text] [Related]
15. Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014.
Healy J; Rodriguez-Lainz A; Elam-Evans LD; Hill HA; Reagan-Steiner S; Yankey D
Vaccine; 2018 Mar; 36(13):1743-1750. PubMed ID: 29483032
[TBL] [Abstract][Full Text] [Related]
16. Middle school vaccination requirements and adolescent vaccination coverage.
Bugenske E; Stokley S; Kennedy A; Dorell C
Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425
[TBL] [Abstract][Full Text] [Related]
17. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009.
Dorell C; Yankey D; Strasser S
Clin Pediatr (Phila); 2011 Dec; 50(12):1116-24. PubMed ID: 21856964
[TBL] [Abstract][Full Text] [Related]
18. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
Walker TY; Elam-Evans LD; Singleton JA; Yankey D; Markowitz LE; Fredua B; Williams CL; Meyer SA; Stokley S
MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):874-882. PubMed ID: 28837546
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
Arguedas A; Soley C; Loaiza C; Rincon G; Guevara S; Perez A; Porras W; Alvarado O; Aguilar L; Abdelnour A; Grunwald U; Bedell L; Anemona A; Dull PM
Vaccine; 2010 Apr; 28(18):3171-9. PubMed ID: 20189491
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
